2024-01-092025-01-312025-01-31false15398352theCOLAB LTD2025-10-02falseiso4217:GBPxbrli:pure153983522024-01-08153983522025-01-31153983522024-01-092025-01-31153983522024-01-07153983522024-01-08153983522024-01-082024-01-0815398352bus:SmallEntities2024-01-092025-01-3115398352bus:AuditExempt-NoAccountantsReport2024-01-092025-01-3115398352bus:FullAccounts2024-01-092025-01-3115398352bus:CompanyLimitedByGuarantee2024-01-092025-01-3115398352core:WithinOneYear2025-01-3115398352core:AfterOneYear2025-01-3115398352core:WithinOneYear2024-01-0815398352core:AfterOneYear2024-01-0815398352core:ShareCapital2025-01-3115398352core:SharePremium2025-01-3115398352core:RevaluationReserve2025-01-3115398352core:OtherReservesSubtotal2025-01-3115398352core:RetainedEarningsAccumulatedLosses2025-01-3115398352core:ShareCapital2024-01-0815398352core:SharePremium2024-01-0815398352core:RevaluationReserve2024-01-0815398352core:OtherReservesSubtotal2024-01-0815398352core:RetainedEarningsAccumulatedLosses2024-01-0815398352core:LandBuildings2025-01-3115398352core:PlantMachinery2025-01-3115398352core:Vehicles2025-01-3115398352core:FurnitureFittings2025-01-3115398352core:OfficeEquipment2025-01-3115398352core:NetGoodwill2025-01-3115398352core:IntangibleAssetsOtherThanGoodwill2025-01-3115398352core:ListedExchangeTraded2025-01-3115398352core:UnlistedNon-exchangeTraded2025-01-3115398352core:LandBuildings2024-01-0815398352core:PlantMachinery2024-01-0815398352core:Vehicles2024-01-0815398352core:FurnitureFittings2024-01-0815398352core:OfficeEquipment2024-01-0815398352core:NetGoodwill2024-01-0815398352core:IntangibleAssetsOtherThanGoodwill2024-01-0815398352core:ListedExchangeTraded2024-01-0815398352core:UnlistedNon-exchangeTraded2024-01-0815398352core:LandBuildings2024-01-092025-01-3115398352core:PlantMachinery2024-01-092025-01-3115398352core:Vehicles2024-01-092025-01-3115398352core:FurnitureFittings2024-01-092025-01-3115398352core:OfficeEquipment2024-01-092025-01-3115398352core:NetGoodwill2024-01-092025-01-3115398352core:IntangibleAssetsOtherThanGoodwill2024-01-092025-01-3115398352core:ListedExchangeTraded2024-01-092025-01-3115398352core:UnlistedNon-exchangeTraded2024-01-092025-01-3115398352core:MoreThanFiveYears2024-01-092025-01-3115398352core:Non-currentFinancialInstruments2025-01-3115398352core:Non-currentFinancialInstruments2024-01-0815398352dpl:CostSales2024-01-092025-01-3115398352dpl:DistributionCosts2024-01-092025-01-3115398352core:LandBuildings2024-01-092025-01-3115398352core:PlantMachinery2024-01-092025-01-3115398352core:Vehicles2024-01-092025-01-3115398352core:FurnitureFittings2024-01-092025-01-3115398352core:OfficeEquipment2024-01-092025-01-3115398352dpl:AdministrativeExpenses2024-01-092025-01-3115398352core:NetGoodwill2024-01-092025-01-3115398352core:IntangibleAssetsOtherThanGoodwill2024-01-092025-01-3115398352dpl:GroupUndertakings2024-01-092025-01-3115398352dpl:ParticipatingInterests2024-01-092025-01-3115398352dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-092025-01-3115398352core:ListedExchangeTraded2024-01-092025-01-3115398352dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-092025-01-3115398352core:UnlistedNon-exchangeTraded2024-01-092025-01-3115398352dpl:CostSales2024-01-082024-01-0815398352dpl:DistributionCosts2024-01-082024-01-0815398352core:LandBuildings2024-01-082024-01-0815398352core:PlantMachinery2024-01-082024-01-0815398352core:Vehicles2024-01-082024-01-0815398352core:FurnitureFittings2024-01-082024-01-0815398352core:OfficeEquipment2024-01-082024-01-0815398352dpl:AdministrativeExpenses2024-01-082024-01-0815398352core:NetGoodwill2024-01-082024-01-0815398352core:IntangibleAssetsOtherThanGoodwill2024-01-082024-01-0815398352dpl:GroupUndertakings2024-01-082024-01-0815398352dpl:ParticipatingInterests2024-01-082024-01-0815398352dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-082024-01-0815398352core:ListedExchangeTraded2024-01-082024-01-0815398352dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-082024-01-0815398352core:UnlistedNon-exchangeTraded2024-01-082024-01-0815398352core:NetGoodwill2025-01-3115398352core:IntangibleAssetsOtherThanGoodwill2025-01-3115398352core:LandBuildings2025-01-3115398352core:PlantMachinery2025-01-3115398352core:Vehicles2025-01-3115398352core:FurnitureFittings2025-01-3115398352core:OfficeEquipment2025-01-3115398352core:AfterOneYear2025-01-3115398352core:WithinOneYear2025-01-3115398352core:ListedExchangeTraded2025-01-3115398352core:UnlistedNon-exchangeTraded2025-01-3115398352core:ShareCapital2025-01-3115398352core:SharePremium2025-01-3115398352core:RevaluationReserve2025-01-3115398352core:OtherReservesSubtotal2025-01-3115398352core:RetainedEarningsAccumulatedLosses2025-01-3115398352core:NetGoodwill2024-01-0815398352core:IntangibleAssetsOtherThanGoodwill2024-01-0815398352core:LandBuildings2024-01-0815398352core:PlantMachinery2024-01-0815398352core:Vehicles2024-01-0815398352core:FurnitureFittings2024-01-0815398352core:OfficeEquipment2024-01-0815398352core:AfterOneYear2024-01-0815398352core:WithinOneYear2024-01-0815398352core:ListedExchangeTraded2024-01-0815398352core:UnlistedNon-exchangeTraded2024-01-0815398352core:ShareCapital2024-01-0815398352core:SharePremium2024-01-0815398352core:RevaluationReserve2024-01-0815398352core:OtherReservesSubtotal2024-01-0815398352core:RetainedEarningsAccumulatedLosses2024-01-0815398352core:NetGoodwill2024-01-0715398352core:IntangibleAssetsOtherThanGoodwill2024-01-0715398352core:LandBuildings2024-01-0715398352core:PlantMachinery2024-01-0715398352core:Vehicles2024-01-0715398352core:FurnitureFittings2024-01-0715398352core:OfficeEquipment2024-01-0715398352core:AfterOneYear2024-01-0715398352core:WithinOneYear2024-01-0715398352core:ListedExchangeTraded2024-01-0715398352core:UnlistedNon-exchangeTraded2024-01-0715398352core:ShareCapital2024-01-0715398352core:SharePremium2024-01-0715398352core:RevaluationReserve2024-01-0715398352core:OtherReservesSubtotal2024-01-0715398352core:RetainedEarningsAccumulatedLosses2024-01-0715398352core:AfterOneYear2024-01-092025-01-3115398352core:WithinOneYear2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:CostValuation2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-092025-01-3115398352core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3115398352core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3115398352core:Non-currentFinancialInstrumentscore:CostValuation2024-01-0815398352core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-0815398352core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-0815398352bus:Director12024-01-092025-01-3115398352bus:Director22024-01-092025-01-3115398352bus:Director32024-01-092025-01-3115398352bus:Director42024-01-092025-01-31

theCOLAB LTD

Registered Number
15398352
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2025

theCOLAB LTD
Company Information
for the period from 9 January 2024 to 31 January 2025

Directors

COLOCCI, Anne Elizabeth Pryor
HODBY, Alexandra, Dr
KHAN, Aryana
MANDER, Claire Robertson

Registered Address

22 Victora Square
London
SW1W 0RB

Registered Number

15398352 (England and Wales)
theCOLAB LTD
Balance Sheet as at
31 January 2025

Notes

2025

£

£

Current assets
Debtors15,082
Cash at bank and on hand214,574
229,656
Creditors amounts falling due within one year4(41,923)
Net current assets (liabilities)187,733
Total assets less current liabilities187,733
Net assets187,733
Capital and reserves
Other reserves187,733
Reserves187,733
The financial statements were approved and authorised for issue by the Board of Directors on 2 October 2025, and are signed on its behalf by:
MANDER, Claire Robertson
Director
Registered Company No. 15398352
theCOLAB LTD
Notes to the Financial Statements
for the period ended 31 January 2025

1.Accounting policies
Statutory information
theCOLAB Ltd is a registered charity in England and Wales and is incorporated. It meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note(s). The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Public benefit entity
All activities reflect the trustees’ duty to provide public benefit as required by section 4 of the Charities Act 2011. The directors confirm they have complied with the Charity Commission’s guidance on public benefit.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
All income is recognised once the charitable company has entitlement to the income, it is probable that the income will be received and the amount of the income receivable can be measured reliably. Donations and legacies Donations are recognised when the charity has been notified in writing of both the amount and settlement date. Donations and legacies include voluntary donations from individuals, corporates and other groups including recovered Gift Aid where appropriate. Donated services Donated services are recognised when the services have been received and the fair value to the charity of the donated service can be measured reliably. Grants receivable Grants, excluding government grants, are recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received, and the amount can be measured reliably and is not deferred. Government Grants are recognised when receivable. Deferred income Deferred income represents amounts received for future periods and is released to incoming resources in the period for which it has been received. Such income is only deferred when: - The donor specifies that the grant or donation must only be used in future accounting periods; or - The donor has imposed conditions which must be met before the charity has unconditional entitlement.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
The charitable company is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charitable company is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gai Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investment with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
Trade and other creditors
Creditors are recognised where the organisation has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Other creditors and accruals are recognised at their settlement amount due.
Financial instruments
The organisation only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
Related parties
Alice Mander, daughter of Claire Mander, was paid £120.00 for event hosting assistance and related expenses. Thea Mander, daughter of Claire Mander, was paid £155.48 for event hosting assistance and related expenses. theCOLAB Temple Ltd donated £415.40 income to the Charity being proceeds from sales of limited edition prints by artist Holly Hendry.
2.Average number of employees

2025
Average number of employees during the year0
3.Further information regarding the company's income
Income consists of cash donations, grants and donated services including Gift Aid where applicable. Legal fees of £61,315 in the period were one-off benefit in kind donated by Debevoise legal services to assist with the charity formation and company structure.
4.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables141
Bank borrowings and overdrafts337
Accrued liabilities and deferred income41,445
Total41,923